Skip to main content
Clinical Trials/TCTR20230330007
TCTR20230330007
Unknown
Phase 3

Prevalence and associated factors of osteoporosis, vascular calcification, vascular stiffness in kidney transplant patients

Ratchadapiseksompotch Fund0 sites400 target enrollmentMarch 30, 2023

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Prevalence and associated factors of osteoporosis, vascular calcification, vascular stiffness in kidney transplant patients
Sponsor
Ratchadapiseksompotch Fund
Enrollment
400
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 30, 2023
End Date
June 30, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ratchadapiseksompotch Fund

Eligibility Criteria

Inclusion Criteria

  • 1\.People who received a kidney transplant for a period of 1 year or more who received treatment at Chulalongkorn Hospital during the years 2001\-2021
  • 2\. Age over 15 years old

Exclusion Criteria

  • 1\. People who are unable to check bone mineral density
  • 2\. People who cannot measure vascular stiffness by Cardio\-ankle vascular index method
  • 3\.Those who received a kidney transplant less than 1 year ago
  • 4\.People who have previously been diagnosed with Osteoporotic fractures
  • 5\.Those who refuse bone density testing Abdominal X\-ray examination or assessment of the hardening of the arteries

Outcomes

Primary Outcomes

Not specified

Similar Trials